Role of oral teriflunomide in the management of multiple sclerosis

QR Code

Role of oral teriflunomide in the management of multiple sclerosis

The landscape of the treatment of relapsing–remitting multiple sclerosis is changing fast. Several oral treatments have shown benefit and generate much interest because of the convenience of their administration. Two oral compounds, fingolimod and teriflunomide, have been approved in relapsing–remit...

Full description

Bibliographic Details
Main Authors:	Tanasescu, Radu, Evangelou, Nikos, Constantinescu, Cris S.
Format:	Article
Published:	Dove Press 2013
Online Access:	https://eprints.nottingham.ac.uk/3057/

Similar Items

The future of multiple sclerosis treatments
by: Coclitu, Catalina, et al.
Published: (2016)

Smoking cessation and the reduction of disability progression in Multiple Sclerosis: a cohort study
by: Tanasescu, Radu, et al.
Published: (2018)

Decreased interferon-β induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis
by: Tanasescu, Radu, et al.
Published: (2016)

Therapeutic cannabinoids in multiple sclerosis: immunomodulation revisited
by: Constantinescu, Cris S., et al.
Published: (2018)

The association between human endogenous retroviruses and multiple sclerosis: a systematic review and meta-analysis
by: Morandi, Elena, et al.
Published: (2017)

Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis
by: Manouchehrinia, Ali, et al.
Published: (2017)

Seven-Tesla magnetization transfer imaging to detect multiple sclerosis white matter lesions
by: Chou, I-Jun, et al.
Published: (2017)

Pediatric multiple sclerosis: update on diagnostic criteria, imaging, histopathology and treatment choices
by: Chou, I-Jun, et al.
Published: (2016)

A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field
by: Cronin, Matthew John, et al.
Published: (2016)

Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study
by: Manouchehrinia, Ali, et al.
Published: (2013)

Functionally relevant white matter degradation in multiple sclerosis: a tract-based spatial meta-analysis
by: Welton, Thomas, et al.
Published: (2015)

Providing emotional support around the point of multiple sclerosis diagnosis (PrEliMS-2): A multiple single case series
by: Thompson, Bethany, et al.
Published: (2023)

Prognostic factors for long-term outcomes in relapsing-remitting multiple sclerosis
by: Traboulsee, Anthony L., et al.
Published: (2016)

Ultra-high-field arterial spin labeling MRI for non-contrast assessment of cortical lesion perfusion in multiple sclerosis
by: Drury, Richard J., et al.
Published: (2018)

Abnormal task driven neural oscillations in multiple sclerosis: a visuomotor MEG study
by: Barratt, Eleanor L., et al.
Published: (2017)

Coordinate based meta-analysis of functional neuroimaging data: false discovery control and diagnostics
by: Tench, Christopher R., et al.
Published: (2013)

Obesity, dieting, and multiple sclerosis
by: Russell, Rebecca, et al.
Published: (2020)

Cognitive rehabilitation for attention and memory in people with multiple sclerosis: study protocol for a randomised controlled trial (CRAMMS)
by: Lincoln, Nadina, et al.
Published: (2015)

Cognitive Rehabilitation for Attention and Memory in people with Multiple Sclerosis: study protocol for a randomised controlled trial (CRAMMS)
by: Lincoln, Nadina B., et al.
Published: (2015)

Memory rehabilitation for people with multiple sclerosis
by: das Nair, Roshan, et al.
Published: (2016)

Cognitive impairment in stroke and multiple sclerosis
by: Belcher, Andrew
Published: (2021)

Brain imaging biomarkers in Multiple Sclerosis
by: Altokhis, Amjad
Published: (2023)

Multiple Sclerosis: A Disease of Affluence?
by: Buchter, B., et al.
Published: (2012)

The unresolved role of the neurologist in providing dietary advice to people with multiple sclerosis
by: Russell, Rebecca, et al.
Published: (2020)

Current evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis
by: Lovelace, Michael D., et al.
Published: (2016)

Deep grey matter and fatigue in multiple sclerosis
by: Niepel, Graham
Published: (2012)

Assessment of mood measures for people with multiple sclerosis
by: Hopkins, Tessa Marie
Published: (2011)

Preventing job loss for people with Multiple Sclerosis
by: De Dios Perez, Blanca
Published: (2022)

The Blood-Brain Barrier integrity and function in ischaemic injury and multiple sclerosis with role of hypothermia
by: Mathur, Manik
Published: (2016)

The viral hypothesis in multiple sclerosis: role of Epstein-Barr virus and human endogenous retroviruses
by: Morandi, Elena
Published: (2017)

Coordinate based meta-analysis does not show grey matter atrophy in narcolepsy
by: Tench, Christopher R., et al.
Published: (2016)

Coordinate based random effect size meta-analysis of neuroimaging studies
by: Tench, Christopher R., et al.
Published: (2017)

Spinal cord grey matter pathology in multiple sclerosis
by: Gilmore, Christopher Patrick
Published: (2008)

Quality of life in informal carers of individuals with multiple sclerosis
by: Topcu, Gogem
Published: (2016)

Imaging markers of brain network disruption in multiple sclerosis
by: Welton, Thomas
Published: (2017)

Multiple Sclerosis Biomarkers – moving towards clinical applications
by: Clarke, Margareta Anna
Published: (2019)

The relation of familial longevity and progression of disability in multiple sclerosis
by: Gao, Xin
Published: (2019)

The impact of the COVID-19 Pandemic on people with Multiple sclerosis
by: Garjani, Afagh
Published: (2024)

Delivery of cannabinoids to specific anatomical regions of the brain following oral administration to reach the site of action for glioblastoma multiforme and multiple sclerosis
by: Brookes, Alice
Published: (2023)

Seeing the invisible: a photovoice exploration of living with, and managing the invisible symptoms of Multiple Sclerosis
by: Parker, L.
Published: (2021)